Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07819474 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Optimizing Tumor-Infiltrating Lymphocyte (TIL) Harvest Site and Patient Selection With CD8-PET Imaging in Patients With

Name: Optimizing Tumor-Infiltrating Lymphocyte (TIL) Harvest Site and Patient Selection With CD8-PET Imaging in Patients With — clinical trial record (NCT07819474)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhaseNot applicable

SponsorM.D. Anderson Cancer Center

Started2027-02-18

View on ClinicalTrials.gov ↗

M.D. Anderson Cancer Center

1,223 trials monitored

See 78 trials at risk

Melanoma

1,020 trials monitored

See 45 trials at risk

To find out if the amount of CD8 immune cells at the place where TIL cells are collected is linked to how well a patient responds to treatment.

Trial Details

NCT Number	NCT07819474
Lead Sponsor	M.D. Anderson Cancer Center Collaborators: ImaginAb, Inc.
Conditions	Tumor Infiltrating Lymphocyte, CD8-PET, Advanced Melanoma
Enrollment	6 participants
Start Date	2027-02-18
Primary Completion	2027-08-31 (estimated)
Study Completion	2030-08-31 (estimated)
Updated on ClinicalTrials.gov	2026-09-15